GOLDMAN SACHS GROUP INC - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 41 filers reported holding CATALYST BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$4,435
-90.4%
21,423
-76.5%
0.00%
Q3 2022$46,000
-78.3%
91,341
-23.3%
0.00%
Q2 2022$212,000
+175.3%
119,144
+1.6%
0.00%
Q1 2022$77,000
-65.0%
117,312
-51.2%
0.00%
Q4 2021$220,000
-66.7%
240,611
+49.7%
0.00%
Q3 2021$660,000
-41.6%
160,701
-38.4%
0.00%
Q2 2021$1,130,000
-14.5%
260,987
-0.5%
0.00%
Q1 2021$1,322,000
-22.3%
262,371
-2.6%
0.00%
Q4 2020$1,701,000
+50.7%
269,465
+2.6%
0.00%
Q3 2020$1,129,000
+21.8%
262,564
+66.3%
0.00%
Q2 2020$927,000
+33.2%
157,929
-0.8%
0.00%
Q1 2020$696,000
+188.8%
159,221
+350.5%
0.00%
Q4 2019$241,000
+21.7%
35,346
-12.2%
0.00%
Q3 2019$198,000
-79.3%
40,238
-69.0%
0.00%
Q2 2019$955,000
+141.2%
129,607
+165.1%
0.00%
Q1 2019$396,000
-9.0%
48,888
-11.2%
0.00%
Q4 2018$435,000
-61.1%
55,071
-46.9%
0.00%
Q3 2018$1,118,000
+753.4%
103,713
+826.3%
0.00%
Q2 2018$131,000
-88.9%
11,197
-75.5%
0.00%
Q1 2018$1,181,00045,7610.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 66,951$13,8590.01%
Colorado Capital Management, Inc. 34,165$70.01%
Nantahala Capital Management 160,430$33,2090.00%
Kynam Capital Management, LP 89,886$18,6060.00%
Keebeck Wealth Management, LLC 20,000$4,1400.00%
MORGAN STANLEY 38,404$7,9500.00%
ACADIAN ASSET MANAGEMENT LLC 259,467$520.00%
BlackRock Inc. 169,904$35,1700.00%
Bank of New York Mellon Corp 200,638$41,5320.00%
Citadel Advisors 5,700$1,1800.00%
View complete list of CATALYST BIOSCIENCES INC shareholders